Arrowpoint Investment Partners »

Amgen shares owned by Arrowpoint Investment Partners

Quarter-by-quarter ownership of Amgen (AMGN) shares owned by Arrowpoint Investment Partners from 13F filings

Historical chart of Arrowpoint Investment Partners investment in Amgen

Tip: Access up to 7 years of quarterly data

All positions including Amgen held by Arrowpoint Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amgen by Arrowpoint Investment Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.6M 5.5k 282.20
2024-12-31 $5.6M 22k 260.64

More positions owned by Arrowpoint Investment Partners

Aegon Amer Reg 1 Cert (AEG)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Select Sector Spdr Tr Sbi Healthcare Call Option (XLV)
Hallador Energy (HNRG)
Echostar Corp Cl A (SATS)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Astera Labs (ALAB)
Atour Lifestyle Hldgs Sponsored Ads (ATAT)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Bristol Myers Squibb Call Option (BMY)
Merck & Co Call Option (MRK)
Pfizer Call Option (PFE)
Abbvie Call Option (ABBV)
Hesai Group Sponsored Ads (HSAI)
Comfort Systems USA (FIX)

View all positions for Arrowpoint Investment Partners

Top funds holding Amgen

Vanguard Group
BlackRock
State Street Corporation
Capital Research and Management Company - Division 3
Capital World Investors
Morgan Stanley
Charles Schwab Investment Management
Geode Capital Management
PRIMECAP Management Company
Wells Fargo & Company
Northern Trust
Capital Research Global Investors
Royal Bank of Canada
Ubs Global Asset Management Americas
Goldman Sachs Group

View all funds holding Amgen